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Abstract: Pulse wave velocity (PWV) and augmentation index (AI)
are independent predictors of cardiovascular health. However, the
comparability of multiple oscillometric modalities currently available
for their assessment was not studied in detail. In the present study, we
aimed to evaluate the relationship between indices of arterial stiffness
assessed by diastolic and suprasystolic oscillometry.
In total, 56 volunteers from the general population (23 males;
median age 70 years [interquartile range: 65–72 years]) were recruited
into observational feasibility study to evaluate the carotid-femoral/
aortic PWV (cf/aoPWV), brachial-ankle PWV (baPWV), and AI
assessed by 2 devices: Vicorder (VI) applying diastolic, right-sided
oscillometry for the determination of all 3 indices, and Vascular
explorer (VE) implementing single-point, suprasystolic brachial oscil-
lometry (SSBO) pulse wave analysis for the assessment of cfPWV and
AI. Within- and between-device correlations of measured parameters
were analyzed. Furthermore, agreement of repeated measurements,
intra- and inter-observer concordances were determined and compared
for both devices.
In VI, both baPWV and cfPWV inter-correlated well and showed good
level of agreement with bilateral baPWV measured by VE (baPWV[VI]–
baPWV[VE]R: overall concordance correlation coefficient
[OCCC]¼ 0.484, mean difference¼ 1.94 m/s; cfPWV[VI]–baPWV[-stin Wirkner, PhD, r, MD,
cholz, PhD
aoPWV[VE]R–baPWV[VE]R: r¼ 0.166; P¼ 0.08). cf/aoPWA(VE)
correlated strongly with AI(VE) (right-sided: r¼ 0.725, P< 0.001). AI
exhibited marginal between-device agreement (right-sided: OCCC¼
0.298, mean difference: 6.12%). All considered parameters showed
good-to-excellent repeatability giving OCCC > 0.9 for 2-point-PWV
modes and right-sided AI(VE). Intra- and inter-observer concordances
were similarly high except for AI yielding a trend toward better reprodu-
cibility in VE (interobserver–OCCC[VI] vs [VE]¼ 0.774 vs 0.844;
intraobserver–OCCC[VI] vs [VE]¼ 0.613 vs 0.769).
Both diastolic oscillometry-derived PWV modes, and AI measured
either with VI or VE, are comparable and reliable alternatives for the
assessment of arterial stiffness. Aortic PWV assessed by SSBO in VE is
not related to the corresponding indices determined by traditional
diastolic oscillometry.
(Medicine 95(10):e2963)
Abbreviations: AI = augmentation index, AI_75 = augmentation
index normalized at heart rate 75 bmp, ao = aortic, AUG =
augmentation pressure, ba distance (VE) = distance (L3–L1), ba
distance (VI) = distance ‘‘center brachial cuff–center ankle cuff’’,
ba = brachial-ankle, ba’ distance (VE) = distance (La–Lb), br =
brachial, cf distance (VE) = distance (2  L2), cf distance (VI) =
distance ‘‘SSN–center of femoral cuff’’, cf = carotid-femoral, L =
left-sided, L1 (VE) = distance ‘‘SSN–center brachial cuff’’, L2
(VE) = distance ‘‘SSN–symphysis’’, L3 (VE) = distance ‘‘SSN–
center ankle cuff’’, La = body height-estimated L3, Lb = body
height-estimated L1, PP = pulse pressure, PTT = pulse transit time,
PWV = pulse wave velocity, R = right-sided, RT = return time, SBP
= systolic blood pressure, SSBO = suprasystolic brachial
oscillometry, SSN = suprasternal notch, VE = Vascular explorer,
VI = Vicorder.
INTRODUCTION
N oninvasive assessment of arterial stiffness is an indepen-dent predictor of all-cause mortality and future cardio-
vascular events in high-risk patients and in the general
population.1,2 Based on a large body of evidence, the aortic
stiffness, expressed as carotid-femoral pulse wave velocity
(cfPWV), is considered a gold standard to estimate cardiovas-
cular risk. Its routine determination is recommended in current
guidelines for the management of arterial hypertension.3 Most
of available devices assess arterial stiffness on the basis of
applanation tonometry and piezoelectric pressure transduction.
Owing to high efforts on operator experience and relatively low
reliability, these techniques did not find implementation in the
every-day practice so far. Pneumatic cuff oscillometryinherent methodological discrepancies,
re feasible measurement alternative.4
medical, Wu¨rzburg, Germany) and
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Arteriograph (Tensiomed, Budapest, Hungary) are 2 most
extensively studied oscillometric devices currently available
on the market, both showing good reliability and comparable
strong relationship between measured cfPWV values and gold
standard.5,6 Very recently, the standard cut-off values for VI
were identified in the general population advocating its use as a
reference oscillometric device.7 In order to determine PWV,
simultaneous, 2-point pulse recordings at diastolic pressure
level are necessary in VI, whereas in Arteriograph, the assess-
ment is reduced to the single-point, suprasystolic brachial
oscillometry (SSBO). This simplification further facilitates
the PWV measurement process and is therefore of particular
interest in clinical routine and epidemiologic research. Another
simplifying alternative to cfPWV is the determination of bra-
chial-ankle PWV (baPWV).8–10 The recently approved device
Vascular Explorer (VE, Enverdis, Jena, Germany) incorporates
both SSBO and baPWV in a user-friendly, comprehensive
assessment of vascular status.
In the present study, we aimed to evaluate the compar-
ability and reliability of arterial stiffness measurements per-
formed by VE and VI in a population-based sample.
METHODS
Study Sample
Repeated measurements of arterial stiffness were per-
formed between December 2010 and April 2011 in a conven-
ience sample of 56 subjects selected from the pilot survey of the
LIFE Project (Leipzig Research Centre for Civilization Dis-
eases) in LIFE Study Ambulance.11 Probands with critical limb
ischemia, ulcera cruris, high-grade carotid atherosclerosis, car-
otid sinus syndrome, angina pectoris, heart insufficiency, ejec-
tion fraction <55%, atrial fibrillation in resting
electrocardiogram, lymphoedema, and paraneoplastic lympha-
denopathy were excluded from the study. All individuals
negated claudication, history of peripheral artery disease, or
peripheral revascularization. Descriptives of study population
can be found elsewhere.12,13 All subjects included in the study
gave their written informed consent. The study was approved by
the local ethical committee and was performed according to the
Declaration of Helsinki.
Teren et alStudy Design
The study design is presented in Table 1. Details can be
found elsewhere.13 In brief, we performed 2 assessments of
TABLE 1. Study Design
Assessment P
Serial Number Initial Subset
1 VE—A VI—A
2 VI—A VE—A
3 VE—B VI—B
4 VI—B VE—B
5 VE—A VI—A
6 VI—A VE—A
7 VE—B VI—B
8 VI—B VE—B
Assessments were performed in the prescribed consecutive order by obs
VE¼Vascular explorer, VI¼Vicorder.
2 | www.md-journal.comarterial stiffness with VI and 2 assessments with VE in alter-
nating order by 1 or 2 observers. All combinations were studied
to avoid sequential effects resulting in 8 study groups. Subjects
were randomly assigned to these groups. All assessments were
performed by the same 2 observers (A/B).
Design of the study allows both, determination of inter-
(study groups 1–4) and intra-observer (study groups 5–8)
reliability as well as comparisons between the devices on the
basis of the same patients. Each assessment is based on 3
measurement replicates.
Since the assessment program of the present study requires
high compliance of individuals, only a limit number of cases
could be assessed. To analyze the impact of our case numbers to
the precision of the quantities of interest, we performed a formal
power/case number analysis using the statistical software pack-
age PASS 2008 (version 08.0.5). For comparison of parameters
between devices we have N¼ 56 cases while for the analysis of
intra- and inter-rater reliability, we have N¼ 28 cases. Results
of analyses can be found in Supplementary Table 1 http://
links.lww.com/MD/A757.
Both devices were configured to perform the complete
noninvasive examination of vascular status; that is, ankle-bra-
chial index (ABI) was determined prior to arterial stiffness
measurements. ABI assessment was validated in both devices in
a separated analysis published elsewhere.12,13 Within each set of
recordings, all parameters of interest were measured in tripli-
cates. In VE, all parameters, including ABI were measured at
the right side, followed by the same measurements at the left
side within the time interval of 10 min.
Determination of Arterial Stiffness
In preparation for this study, observers were trained for
both automated devices according to the instructions of the
manufacturers and own standard operating procedures (in Ger-
man; available upon request). Technical handling was practiced
in a training sample of 20 probands prior to the study. All
measurements were performed in quiet, well-aired, and
temperature-controlled room. Subjects were placed in a supine
position for at least 10 min before starting the assessment. All
subjects were asked to avoid speaking, and encouraged to
breathe calmly during the measurements.
The following parameters were assessed using both VE
Medicine  Volume 95, Number 10, March 2016and VI: brachial (brSBP) and aortic systolic pressure (aoSBP);
brachial (brPP) and aortic pulse pressure (aoPP); brachial
(brAUG) and aortic augmentation pressure (aoAUG). Brachial
lan
Repetition Subset Number of Probands
VE—B VI—B 7
VI—B VE—B 7
VE—A VI—A 7
VI—A VE—A 7
VE—A VI—A 7
VI—A VE—A 7
VE—B VI—B 7
VI—B VE—B 7
erver A and observer B, respectively.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 1. Example of pulse wave recording output in vascular explorer implementing the reflectionmethod. AIX¼ augmentation index,
baPWV¼brachial-ankle pulse wave velocity, BP ao¼ aortic blood pressure, BP br¼brachial blood pressure, cfPWV¼ carotid-femoral wave
velocity, ED¼ ejection duration, P0¼beginning of the forward pressure wave, P1¼peak of the forward pressure wave, P2¼peak of the
ed
Medicine  Volume 95, Number 10, March 2016 Oscillometry for the Assessment of Aortic Stiffnessand aortic augmentation index (AI) were calculated by the
formula: AI¼ aoAUG/aoPP.
Next, anatomically distinct, in part device-specific PWV
modes were determined as ratio of pulse travel distance to pulse
transit time (PTT) derived from 2-point diastolic pulse
wave analysis and pulse return time (RT) derived from
SSBO, respectively.
PTT in VI was determined from foot-to-foot real time shift
between simultaneous 2-point-recorded pulse wave curves
using in-built cross-correlation algorithm centered on the peak
of the second derivative of the pressure curve. Pulse waves were
recorded upon automatic cuff inflation to approximately 60 mm
Hg over at least 10 pulsations in the following 2 anatomical
combinations: carotid-femoral (cf) and brachial-ankle (ba).
Finally, AI was in VI assessed applying device-specific brachial
pulse wave analysis.
In VE, brachial-ankle pulse transit time (baPTT) necessary
for the calculation of brachial-ankle PWV assessed by VE
[baPWV(VE)] was determined by device-specific algorithm
detecting the real time foot-to-foot difference between brachial
and ankle pulse wave. For the determination of baPWV(VE),
both measured [baPWV(VE)], and body height-estimated
[ba’PWV(VE)] brachial-ankle travel distance was considered.
VE-derived AI(VE) and aoPWV(VE) were calculated using
aoAUG, aoPP, and RT that were derived from SSBO (i.e.,
analysis of pulse waves recorded upon complete arterial occlu-
sion at the brachial cuff pressure by about 35 mm Hg above the
systolic pressure). RT was assessed applying the reflection
method based on measurement of time difference between
beginning of the forward and reflected travelling wave acquired
by decomposition of the SSSBO pulse recordings (Figure 1).
Additionally, the aoPWV values were converted into Sphyg-
mocor-related cfPWV values using formula provided by the
reflected pressure wave, RT¼return time/beginning of the reflectmanufacturer. For this reason, cfPWV(VE) is reported simul-
taneously with aoPWV(VE) (i.e., cf/aoPWV[VE]). Considered
parameters of vascular stiffness and the method of their
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.assessment are summarized in device-specific manner in
pressure wave (modified from www.enverdis.de).Table 2 (for details see also list of abbreviations).
In both devices, the following criteria were applied to
rove the quality of pressure pulse wave recording:
correct application of the cuffs and the neck band andapp
1.
2. PWV-variance of max. 1 m/s over the 10 heart beats
recorded artifact-rich recordings were excluded from
the analysis.
All travel distances were measured separately for each
assessment using a flexible tape as indicated in Figures 2 and 3,
respectively. In case of significant android adipositas, a slide
calliper was used. Data regarding the acceptability and global
time requirements for both devices were collected and pub-
lished elsewhere in detail.13
Statistical Analysis
Descriptive statistics are based on averaged measurement
triplicates. Paired t test was used to compare first and second
measurement series of each device. PWVand AI measurements
e further analyzed in order to address the following ques-
s:
Within- and between-device relationship between PWVand1.
AI determined by VE and VI, respectively. This analysis is
based on the measurements averaged over the first
measurement triplicate of each device.
Agreement of right-sided with left-sided PWV and AI2.
results of VE.
Reliability of repeated measurements that is within-set
agreement of PWV- and AI-triplicates (VE and VI).
Inter-observer reliability of averaged PWV and AI
measurements (VE and VI, averages were calculated over
the 3 measurement replicates) based on groups 1 to 4 of our
study (see Table 1).
www.md-journal.com | 3
TABLE 2. Device-Specific Calculation and Underlying Assessment Method Applied for the Determination of Considered Arterial
Stiffness Parameters
VI (Unilateral, Right-Sided) VE (Bilateral)
Calculation Formula
Underlying Assess-
ment Modality Calculation Formula
Underlying Assessment
Modality
cfPWV cfPWV (VI)¼ cf distance
(VI)/cfPTT (VI)
Diastolic, 2-point foot-
to-foot PTT
cfPWV (VE)¼ cf
distance (VE)/RT
Suprasystolic pulse wave
reflection analysis
aoPWV (VE) – – aoPWV
(VE)¼Sphygmocor-
derived aoPWV
approximation
Suprasystolic pulse wave
reflection analysis
baPWV baPWV (VI)¼ ba distance
(VI)/baPTT (VI)
Diastolic, 2-point foot-
to-foot PTT
baPWV (VE)¼ ba
(measured travel
distance) (VE)/baPTT
(VE)
Diastolic, 2-point foot-to-
foot PTT
AI AI (VI)¼ aoAUG (VI)/
aoPP (VI)
Diastolic pulse wave
analysis
AI (VE)¼ aoAUG
(VE)/aoPP (VE)
Suprasystolic pulse wave
reflection analysis
AI_75 (VE) – – AI_75 (VE)¼AI (VE)
normalized at heart
rate 75 bmp
Suprasystolic pulse wave
reflection analysis
AI¼ augmentation index, AI_75¼ augmentation index normalized at heart rate 75 bmp, aoAUG¼ aortic augmentation pressure, aoPP¼ aortic
nkle
ave
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¼ caare
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Tab
4 |pressure, aoPWV¼ aortic pulse wave velocity, baPTT¼ brachial-a
rotid-femoral pulse transit time, cfPWV ¼ carotid-femoral pulse w
orer, VI ¼ Vicorder.5. Intra-observer reliability of averaged PWV and AI
measurements (VE and VI) based on groups 5 to 8 of
our study (see Table 1).
Agreement of measurements was evaluated using concor-
dance correlation coefficients (CCC).14 CCC values range
between 1 and 1 were the latter means perfect agreement.
This is achieved if and only if the mean difference between the
samples is zero (i.e., no systematic bias), the correlation is 1 and
the variances are the same. Similarly, the overall concordance
correlation coefficient (OCCC) measures the agreement of more
than 2 groups. After Fisher transformation, we calculated Jack–
Knife standard errors to establish confidence limits of concor-
dance coefficients.15
Analogously, we established formal statistical tests of the
differences of 2 CCC based on the same samples by estimating
Jack–Knife standard errors of the difference of 2 CCCs.
Type 1 error is controlled at 5% throughout, that is, no
corrections for multiple testing were performed. All analyses
were implemented and performed using the statistical software
package R 2.13.1 (www.r-project.org).
RESULTS
Study sample comprises of 23 males and 33 females of
median age¼ 69.5 years (interquartile range [IQR]¼ 65.0–
72.0 years) and median body mass index¼ 27.4 kg/m2
(IQR¼ 25.4–30.7 kg/m2).
In 26 subjects, an elevated systolic brachial blood pressure
140/90 mm Hg was observed based on oscillometric measure-
ments prior to pulse wave analysis averaged over the 3 measure-
ments. Sex-specific distributions of basic sample characteristics
explpresented in Table 3. Descriptive statistics of all parameters
sidered for VE and VI are presented in Supplementary
le 2, http://links.lww.com/MD/A757.
www.md-journal.comRelationship Between Multimodal Determinants
of Arterial Stiffness
Within-Device Associations Between Arterial
Stiffness Parameters
Considering distinct PWV measurement modalities
assessed by the same device, we found moderate correlation
between both PWV modes in VI (cfPWV–baPWV: r¼ 0.691,
P< 0.001; OCCC¼ 0.253, mean difference¼ 2.95 m/s;
Figure 4). Furthermore, AI (VI) displayed no relationship with
PWV and peripheral blood pressures, respectively (Figure 4;
Supplementary Table 2, http://links.lww.com/MD/A757).
In VE, cf/aoPWV(VE) exhibited no significant correlation
with ipsilateral baPWV(VE) (r¼ 0.166; P¼ 0.08, Figure 5). In
contrast to VI, cf/aoPWV(VE), but not baPWV(VE), showed
strong positive correlation with AI, more pronounced in right-
sided ipsilateral comparisons (r¼ 0.725; P< 0.001 for
cfPWV(VE)R, Figure 5). In both devices, baPWV and cfPWV
showed weak-to-moderate correlation with brachial and bilat-
eral ankle pressures. AI(VE), but not AI(VI), correlated weakly
with peripheral pressures. No correlations with ABI values were
found (Supplementary Tables 3–5, http://links.lww.com/MD/
A757).
Analyzing the relationship between aortic AI and brachial
AI that is derived from brachial pulse wave analysis, strong
correlation in VI was observed (r¼ 0.768, P< 0.001). Analo-
gous analysis in VE revealed perfect linear relationship between
central and brachial AI (r¼ 1.000, P< 0.001; Supplementary
Tables 3–5, http://links.lww.com/MD/A757).
In VE, the agreement between right-sided and left-sided
mean values from the first measurement triplicate was evaluated
pulse transit time, baPWV¼ brachial-ankle pulse wave velocity, cfPTT
velocity, PTT ¼ pulse transit time, RT ¼ return time, VE ¼ Vascular(Table 4). In general, the side agreement of the measurements
was good-to-moderate, giving the best results for AI_75(VE)
values and the lowest concordance for cf/aoPWV(VE). A
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 3. Differences in assessment of travel distance for
Medicine  Volume 95, Number 10, March 2016 Oscillometry for the Assessment of Aortic Stiffnesssignificant side-related bias of mean ao/cfPWV(VE) was
observed giving higher values measured on the right side (mean
difference cfPWV[VE]¼ 0.732 m/s, P¼ 4.51 106; Table 4).
Between-Device Relationship of Arterial Stiffness
Indices
Analyzing the differences between both tested devices,
baPWV(VE) was in strong-to-moderate association with both
FIGURE 2. Differences in assessment of baPWV pulse wave travel
distance in (A) Vicorder and (B) Vascular explorer. baPWV¼
brachial-ankle pulse wave velocity, SSN¼ suprasternal notch.PWV modes determined by VI (baPWV[VI]–baPWV[VE]R:
r¼ 0.808; OCCC¼ 0.484, mean difference¼ 1.94 m/s;
cfPWV[VI]–baPWV[VE]R: r¼ 0.596; OCCC¼ 0.493, mean
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.difference¼ 1.0 m/s; P< 0.001 for both comparisons; Table 5).
As anticipated, this relationship was slightly more pronounced
for ipsilateral (right-sided) comparisons (to compare the left-
(A) cfPWV in Vicorder, and (B) cf/aoPWV in Vascular explorer.
cf/aoPWV¼ carotid-femoral/aortic pulse wave velocity, , cfPWV¼
carotid-femoral pulse wave velocity, SSN¼ suprasternal notch.sided analysis, see Supplementary Table 6, http://links.lww.
com/MD/A757). In contrast, cf/aoPWV(VE) displayed a weak
correlation with cfPWV(VI) (r¼ 0.196, P¼ 0.04). Considering
www.md-journal.com | 5
TABLE 3. Basic Characteristics of the Study Sample
All (n¼ 56) Males (n¼ 23) Females (n¼ 33)
Age, y 70 (65–72) 69 (66–72) 70 (63–72)
BMI 27.4 (25.3–31.0) 26.7 (25.2–30.0) 27.4 (24.7–31.6)
brSBP, mm Hg 138.5 (126.6–147.9) 138.1 (126.2–148.6) 138.9 (126.7–149.0)
brDBP, mm Hg 78.9 (73.2–83.2) 81.1 (73.1–83.2) 77.9 (73.2–83.2)
Hypertension 26 (46.4) 10 (43.5) 16 (48.5)
brS
Teren et al Medicine  Volume 95, Number 10, March 2016the between-device relationship of AI, a weak-to-moderate
correlation between AI(VI) and AI(VE) was found (right-sided:
r¼ 0.486; P< 0.001; Table 5). Moreover, AI(VI) exhibited a
weak association with cf/aoPWV(VE) (right-sided: r¼ 0.297;
P¼ 0.01). The same analysis was performed using pulse wave
travel times and RT, respectively, thereby eliminating the
differences in travel distances.Using this approach, similar results
were found showing strong correlation between baPTT(VI) and
Values are indicated as n (%) or median (25–75 IQR).
BMI¼ body mass index, brDBP¼ brachial diastolic blood pressure,baPTT(VE) (r¼ 0.880;P< 0.001) and weak correlation between
cfPTT(VI) and RT(VE) (right-sided: r¼ 0.323; P< 0.001;
OCCC¼ 0.264, mean difference¼ 7.14 ms).
baPWV
8 10
8
10
12
14
0.691
cfPW
10 14 18
-0.053 0.01
FIGURE 4. Within-device correlation between baPWV (scale ‘‘10, 14
assessed by Vicorder. We present Pearson correlation coefficients.

P<
ankle pulse wave velocity, cfPWV¼ carotid-femoral pulse wave veloci
6 | www.md-journal.comTo evaluate interchangeability, we finally assessed the
between-device agreement of equivalent parameters revealing
strong concordance between bilateral baPTT(VE) and
baPTT(VI) (right side: OCCC¼ 0.870, mean difference¼
0.339 ms; left side: 0.828, mean difference¼ 1.28 ms). Analyz-
ing device equivalents for baPWV, the concordance was higher
when ba’PWV(VE) that implements body height-derived pulse
wave travel distances was considered (right side:
BP¼ brachial systolic blood pressure, IQR ¼ interquartile range.OCCC¼ 0.757, mean difference¼ 0.695 m/s; left side:
OCCC¼ 0.645, mean difference¼ 0.862 m/s). AI(VI) exhibited
marginal concordance with AI(VE) (right side: OCCC¼ 0.298,
12 14
10
14
18
V
9
5 15 25
5
15
25AI
, 18’’), cfPWV (scale ‘‘8, 10, 12, 14’’), and AI (scale ‘‘5, 15, 25’’)
0.05,

P<0.001. AI¼ augmentation index, baPWV¼brachial-
ty.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
baPWV(VE)R
6 8 12 16
8
10
14
6
8
12
16
0.166
cfPWV(VE)R
8 10 14
0.104 0.725
10 20 30 40
10
20
30
40AI(VE)R
FIGURE 5. Within-device correlation between right-sided baPWV (scale ‘‘8, 10, 14’’), cfPWV (scale ‘‘6, 8, 12, 16’’), and AI (scale ‘‘10, 20,
ente
hial
Medicine  Volume 95, Number 10, March 2016 Oscillometry for the Assessment of Aortic Stiffnessmean difference¼ 6.12%; left side: OCCC¼ 0.324, mean
difference¼ 5.32%).
Reliability
Concordance of Within-Subset Repeated
30, 40’’) assessed by Vascular explorer. Results for left side are pres
P<0.05,

P<0.001. AI¼ augmentation index, baPWV¼brac
velocity, VE¼Vascular explorer.Measurements
Analysis considering the first measurement triplicates
revealed good-to-excellent concordances of repeated
TABLE 4. Concordance of Right- vs Left-Sided Measurements in
Trait OCCC CI_low CI_upp
baPWV (VE) 0.838 0.725 0.907
aoPWV (VE) 0.793 0.691 0.864
cfPWV (VE) 0.794 0.693 0.865
AI (VE) 0.933 0.889 0.960
AI_75 (VE) 0.934 0.887 0.962
AI¼ augmentation index, AI_75¼ augmentation index normalized at hear
ankle pulse wave velocity, cfPWV¼ carotid-femoral pulse wave velocit
OCCC¼ overall concordance correlation coefficient, VE¼Vascular explor
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.measurements in both devices (VI: OCCC range 0.728
[0.534–0.850] for AI(VI) to 0.952 [0.919–0.972] for baPWV
(VI); VE: OCCC range 0.802 [0.639–0.896] for cf/aoPWV
(VE)R to 0.929 [0.867–0.962] for AI_75(VE)R, see Supple-
mentary Table 7, http://links.lww.com/MD/A757). Pair-wise
concordances did not differ significantly between first and
d in the supplement. We present Pearson correlation coefficients.
-ankle pulse wave velocity, cfPWV¼ carotid-femoral pulse wavesecond, first and third, or second and third measurements.
The normalization of AI(VE) values for heart beat revealed
no relevant change in concordance.
Vascular Explorer
Mean Difference P Value r
0.086 0.464 0.839
0.491 4.63 106 0.852
0.732 4.51 106 0.853
0.792 0.0667 0.938
0.826 0.0737 0.939
t rate 75 bmp, aoPWV¼ aortic pulse wave velocity, baPWV¼ brachial-
y, CI_low/upp¼ upper and lower limit of 95% confidence interval,
er.
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TABLE 5. Between Device Pearson Correlation Matrix
Comparing PWV and AI Determined by VI vs (VE)R
Trait baPWV (VI) cfPWV (VI) AI (VI)
baPWV (VE)R 0.808

0.596
 0.012
ba’PWV (VE)R 0.825

0.583
 0.069
aoPWV (VE)R 0.160 0.196

0.247

cfPWV (VE)R 0.160 0.195

0.245

AI (VE)R 0.157 0.066 0.486

AI_75 (VE)R 0.148 0.037 0.500

AI¼ augmentation index, AI_75¼ augmentation index normalized
at heart rate 75 bmp, aoPWV¼ aortic pulse wave velocity, baPWV¼
brachial-ankle pulse wave velocity applying brachial-ankle travel dis-
tance estimated from the body height, cfPWV¼ carotid-femoral pulse
wave velocity, R¼ right side, VE¼Vascular explorer, VI¼Vicorder.
Teren et alInter- and Intra-Observer Concordance
Series 1–4 were designed to estimate the inter-observer
concordance of the automated devices. Both methods showed
good inter-observer agreement, and no significant between-
observer bias, except for right-sided cf/aoPWV(VE)R
(bias¼ 0.542; P¼ 0.010 for cfPWV(VE)R; bias¼ 0.363;
P¼ 0.010 for aoPWV(VE)R, respectively; Supplementary
Table 8, http://links.lww.com/MD/A757).
Considering series number 5–8, VI and VE showed good
agreement of first and second measurements performed by the
same observer. The strongest concordance was shown for
baPWV(VI) (OCCC 95% CI: 0.900; 0.808–0.949), the lowest
for AI(VI) (OCCC 95% CI: 0.613; 0.307–0.804; Supplementary
Table 9, http://links.lww.com/MD/A757), both determined by
VI. In VE, the left-sided measurements of cf/aoPWV(VE)L
exhibited slightly lower concordance then the right-sided values
(Supplementary Table 9, http://links.lww.com/MD/A757).
DISCUSSION
In the present study, we evaluated the multimodal
assessment of arterial stiffness by comparing an established
oscillometric device VI with VE that implements both dias-
tolic, 2-point oscillometry for baPWV measurement, and
SSBO for the determination of cf/aoPWV and AI. To our
best knowledge, this is the first comprehensive report on
fundamental differences between distinct anatomical and
computational oscillometric approaches analyzed in within-
device and between-device manner.
Carotid-Femoral, Aortic PWV, and AI
Guideline-determined cfPWV values >10 m/s associate
with higher cardiovascular risk.16 Two-point cfPWV assessed
by VI showed good reliability and correlation with alternative
baPWV. Contrary, the ipsilateral and contralateral reproduci-
bility of cfPWV recordings in VE was lower and cfPWV(VE)
displayed no relevant association with other PWV modes.
Furthermore, unlike the PWV assessed by 2-point recordings,
cfPWV(VE) showed significant relationship with AI. These
P< 0.001.
P< 0.05.results suggest that SSBO-based assessment of central
PWV has weak or no relationship with the traditional 2-point
oscillometry.
8 | www.md-journal.comFor the assessment of cf/aoPWV(VE) an SSBO was used
implementing the decomposition and analysis of the aortic pulse
wave derived from oscillation recorded upon brachial artery
occlusion. Relationship observed between SSBO-derived
cfPWV(VE) and AI (VE) can be explained by the fact that
both parameters are calculated using correlated indices, that is,
amplitude difference between forward and reflection wave (AI),
and the velocity of wave reflection, expressed as RT
(cfPWV).17 Aortic PWV acquired using SSBO was analysed
in 1 study on 20 patients with cardiovascular disease and 24
controls, revealing moderate correlation with SphygmoCor, and
Arteriograph.18 Horva´th et al validated SSBO against gold
standard invasive measurements and showed an acceptable
agreement. However, the conclusions drawn from this study
are limited by its small sample size.19 Additionally, several
authors report on lack of validity of the SSBO working principle
and discuss the possibility that SSBO predominantly assess
brachial stiffness inter-correlating with central stiffness.20,21
The strong correlation observed in the present study between
brachial AI(VE), central AI(VE), and cf/aoPWV(VE) further
underpins this hypothesis.
In contrast to the PWV, neither aoPP nor aoAUG necessary
for AI computation exhibit direct relationship to central arterial
stiffness. Moreover, AI is influenced by additional factors,
including sex, body weight, height, heart rate, and medication
modulating peripheral resistance.22 In a recent invasive study,
Sakurai et al23 demonstrated that PWV measured in aorta lacks
association with AI and both indices cannot be used inter-
changeably. These findings are in line with our results showing
no association between PWV and AI when diastolic, 2-point
PWV modes are considered. Finally, substantially different
pressure levels applied during the pulse wave recordings for
AI determination in VI, and VE might explain the observed
weak association between AI(VI) and AI(VE).
Brachial-Ankle PWV
The measurement of baPWV emerged recently for esti-
mation of vascular stiffness and is considered more feasible
promising better patient compliance. Similarly to ABI, 2-point
measurement is necessary at the ankle and brachial side for this
modality. In the present study, baPWV was assessed applying
analogous techniques in both VI and VE. In agreement with
previous studies, we observed a systematic shift of baPWV values
being about 20% higher than cfPWV(VI).24,25 Furthermore, we
found a good-to-excellent within- and between-device agreement
of baPWV. Considering high concordance of baPTT values, both
devices can be used interchangeably for baPWV assessment upon
equalizing the measurements of pulse wave travel distance.
Sugawara et al26 demonstrated a substantial role of baPWV
for the prediction of central vascular stiffness; however, this
relation might be blurred by the (considerable) contribution of
the peripheral arterial stiffness owing to the anatomical local-
ization of the baPWV recording sites, particularly in case of
suspected peripheral artery disease. Brachial-ankle PWV dis-
played no relevant association with AI or ABI that are both
influenced by peripheral arterial stiffness. However, a signifi-
cant correlation of baPWV with brachial and ankle pressures
was observed. The independent association between arterial
stiffness and peripheral blood pressure is well documented 27
and the significant left–right difference in ankle pressures was
Medicine  Volume 95, Number 10, March 2016recently found to associate with unequal arterial stiffness
expressed by baPWV.28 Additionally, both inter-arm and
inter-ankle systolic pressure difference was shown to predict
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
cardiovascular morbidity and mortality.29,30 Considering the
significant side-related bias of stiffness indices found in VE, our
results favor the bilateral assessment of baPWV.
Several limitations of our study are worthy of note. First,
we analyzed a sample of voluntary subjects of older age with a
substantial portion of patients with hypertension. However, this
enabled us to study the determinants of arterial stiffness at a
broader range of blood pressure values. Second, VI was used as
standard noninvasive device in the present study, although
lacking the validation against invasively assessed arterial stiff-
ness. Besides this limitation, we believe that VI is the most
convenient alternative, since the measurement principle of this
device is based on oscillometry in standard 2-point recording
modus which is comparable to that of VE. Several studies
showed that comparisons between devices with distinct core
working principles reveal considerable discrepancies further
limiting their comparability.31
In conclusion, PWV and AI assessed by diastolic pulse
oscillometry are both in VE and VI convenient and reliable for
routine assessment of arterial stiffness. The determination of
baPWV represents feasible alternative to the traditional 2-point
cfPWV, meriting further evaluation in prospective population
cohorts. Aortic PWA determined by SSBO displayed no
relevant relationship to the corresponding diastolic oscillome-
try-derived parameters.
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